Opening book details…
About this Medicine article
Efficacy and safety of guselkumab compared with adalimumab for the treatment of moderate-to-severe psoriasis: Results from the phase 3, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Publisher
- Elsevier Science; Elsevier ; Mosby Inc.; Elsevier BV (ISSN 1097-6787)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)